- Home
- VINP vs TLRY Comparison
VINP vs TLRY Comparison
Compare VINP & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VINP | TLRY |
|---|---|---|
| Founded | 2009 | N/A |
| Country | Brazil | Canada |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 638.8M | 570.4M |
| IPO Year | 2020 | 2018 |
Fundamental Metrics
Financial Performance| Metric | VINP | TLRY |
|---|---|---|
| Price | $10.05 | $4.56 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | $14.00 | ★ $72.33 |
| AVG Volume (30 Days) | 25.9K | ★ 4.6M |
| Earning Date | 05-11-2026 | 04-01-2026 |
| Dividend Yield | ★ 5.72% | N/A |
| EPS Growth | N/A | ★ 55.69 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $18.07 | $8.79 |
| Revenue Next Year | $12.74 | $19.98 |
| P/E Ratio | $24.41 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.29 | $0.72 |
| 52 Week High | $13.61 | $15.70 |
Technical Indicators
Market Signals| Indicator | VINP | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 53.70 | 50.89 |
| Support Level | $9.87 | $4.20 |
| Resistance Level | $10.28 | $4.85 |
| Average True Range (ATR) | 0.24 | 0.23 |
| MACD | 0.03 | 0.08 |
| Stochastic Oscillator | 86.67 | 60.63 |
Price Performance
Historical ComparisonAbout VINP Vinci Partners Investments Ltd.
Vinci Compass Investments Ltd is an alternative investment platform in Brazil offering asset management, wealth management, and financial advisory services. The company comprises of six business lines i) Global IP&S, (ii) Credit (including public & private credit, opportunistic capital solutions, and agribusiness credit), (iii) Private Equity, (iv) Equities, (v) Real Assets (including real estate, infrastructure and forestry) and (vi) Corporate Advisory.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.